ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,349Medicare Part D Prescriptions Filled, Including Refills

Rank: 376 out of 5176

$661K Total Retail Price of All Prescriptions

Rank: 695 out of 5176

429 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 11,063 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,007 892 1 1
HYDROCHLOROTHIAZIDE 577 511 2 10
METFORMIN HCL 475 422 3 7
LOSARTAN POTASSIUM 440 416 4 14
LISINOPRIL 432 407 5 5
GLYBURIDE 369 321 R 6 67
ATENOLOL 343 294 7 12
AMLODIPINE BESYLATE 333 311 8 2
ALENDRONATE SODIUM 324 323 9 18
FOSINOPRIL SODIUM 301 232 10 105
FUROSEMIDE 300 282 11 8
METOPROLOL TARTRATE 296 274 12 6
NIFEDIPINE ER 272 246 13 48
NEXIUM 250 240 14 16
OMEPRAZOLE 241 201 15 3
LEVOTHYROXINE SODIUM 223 202 16 4
CRESTOR 216 198 17 15
JANUVIA 189 168 18 25
FLUTICASONE PROPIONATE 188 166 19 38
ADVAIR DISKUS 178 163 20 32
FELODIPINE ER 177 161 21 128
TAMSULOSIN HCL 158 142 22 20
IBUPROFEN 141 104 23 72
CARVEDILOL 136 136 24 24
LANTUS 125 119 25 66
LOVAZA 122 120 26 43
PLAVIX 118 114 27 29
RANITIDINE HCL 115 115 28 36
FINASTERIDE 110 109 29 69
CLOPIDOGREL 109 104 30 26
DIOVAN 104 104 31 19
METOPROLOL SUCCINATE 102 102 32 11
GABAPENTIN 100 85 33 21
LABETALOL HCL 97 74 34 114
INSULIN SYRINGE 95 94 35 137
FLUOCINONIDE 91 80 36 165
PRANDIN 86 79 37 150
TERAZOSIN HCL 86 77 37 158
ATORVASTATIN CALCIUM 84 76 39 9
JANUMET 76 54 40 77
ALCOHOL SWABS 76 54 40 115
SINGULAIR 75 64 42 62
ACTONEL 75 75 42 134
PROAIR HFA 68 61 44 60
VENTOLIN HFA 65 54 45 64
DONEPEZIL HCL 64 64 46 28
PATANOL 63 58 47 158
PRAVASTATIN SODIUM 63 63 47 23
LIPITOR 56 56 49 51
NAMENDA 54 54 50 47
AMMONIUM LACTATE 54 32 50 91
ALLOPURINOL 54 52 50 41
LOSARTAN-HYDROCHLOROTHIAZIDE 53 49 53 35
MICARDIS 53 53 53 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.